Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: PDT, FDA

Inovytec's Ventway Sparrow Line of Ventilators Receives FDA 510(k) Clearance to Market


RA'ANANA, Israel, Feb. 2, 2021 /PRNewswire/ -- Inovytec, an innovator of multi-functional and user-friendly critical medical devices, announced today that it was granted FDA 510(k) clearance to market and sell its Ventway Sparrow ventilators in the United States. The ventilators are already commercialized in Europe, Canada and Australia and undergoing registration procedures in other countries.

The Ventway Sparrow transport and emergency ventilators are designed for mobility, high-performance and ease of use. They weigh only ~1 kilogram (2.2 pounds) and allow for both invasive and noninvasive ventilation for patients weighing above 5 kg. A built-in turbine removes dependency from external oxygen supply and serves as a cooling system, while an optional quick start mode allows for ventilation to start within five seconds after three clicks. An internal battery provides up to 4.5 hours of operation.

Three different Ventway Sparrow models are designed to meet the needs and the standards set by various market segments:

It has been chosen also for fighting COVID-19 epidemic in Italy, Spain, UK, South-Africa, Russia and Israel and had previously been cleared for use in the United States under FDA Emergency Use Authorization.

"Inovytec's mission is to develop critical medical solutions that strengthen every step of the chain of survival," said Udi Kantor, Co-founder, and CEO of Inovytec. "This important milestone allows our ventilators to aid healthcare providers in the US to safely and easily treat and transfer patients. We are confident that due to its ultra-portability, high-performance, ease of use and low maintenance needs, the Ventway family will aid medical staff in the field and during the transportation of ventilated patients."

About Inovytec

Inovytec's family of innovative medical solutions address the critical moments of care, from the first minutes after a medical event to patient transfers and stabilization in hospitals. SALI creates a virtual hospital environment in the field and allows for citizens to act as first responders during critical emergencies from first aid to resuscitation with on-line communication to a remote medical center. Ventway is the most portable advanced ventilator system available, with specialty ventilators for the hospital, military, EMS and soon homecare mobility environments. Lubo is a first-line airway management tool for EMS teams and first responders, which also includes neck stabilization for trauma patients. Each product's goal is to strengthen the healthcare continuum in the chain-of-survival and improve outcomes in both routine and emergency medical events. The company was founded in 2011.

Media Contact:
Avi Bieler
Finn Partners
[email protected]
+972-54-941-5432

 

SOURCE Inovytec


These press releases may also interest you

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...



News published on and distributed by: